Protein kinases play a key role in cellular signaling, and they have proven to be druggable and clinically important. Protein kinase A (PKA) is capable of regulating a large number of processes, including growth, development, memory, metabolism, and gene expression. Dysregulation and mutation of PKA can even lead to cancer, making protein kinases important targets for the treatment of a variety of serious diseases. The reproducible recombinant expression, stability and crystalline nature of PKA make this unique kinase a valuable research tool. In recent years, PKAs have gained a wide attention as diagnostic biomarkers due to their overexpression and plasma secretion to blood plasma with several cancers. In addition, cyclic adenosine monophosphate (cAMP) can regulate cellular processes, making PKA an ‘antitarget’ for most protein kinase inhibition strategies. Therefore, many scientists are committed to investigating potent and selective inhibitors of protein kinase A.
BOC Sciences has developed a c-AMP dependent protein kinase targeted library of inhibitors of protein kinase A.
Figure 1. Schematic diagram of the cAMP/PKA signalling pathway. (Nancy, G.; et al. 2008)
Polar contacts with Val123, Thr183 and Glu121 are defined as docking constraints
BOC Sciences provides professional, rapid and high-quality services of c-AMP Dependent Protein Kinase (PKA) Targeted Library design at competitive prices for global customers. Personalized and customized services of c-AMP Dependent Protein Kinase (PKA) Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.